Literature DB >> 29880309

Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy.

Fei Yi1, Nicholas Frazzette1, Anthony C Cruz1, Christopher A Klebanoff2, Richard M Siegel3.   

Abstract

Originally discovered as an inducer of apoptosis, the TNF-family receptor Fas (CD95, APO-1, TNFRSF6) has more recently been found to have functions beyond cell death, including T cell co-stimulation and promoting terminal differentiation of CD4+ and CD8+ T cells. Other TNF family members also discovered as apoptosis inducers, such as TRAIL (APO-2L, TNFSF10), can promote inflammation through caspase-8. Surprisingly, non-apoptotic signaling through Fas can protect from the autoimmunity seen in Fas deficiency independently from the cell death inducing functions of the receptor. Non-apoptotic Fas signaling can induce tumor cell growth and migration, and impair the efficacy of T cell adoptive immunotherapy. Blocking of non-apoptotic functions of these receptors may be a novel strategy to regulate autoimmunity and inflammation, and enhance antitumor immunity.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29880309      PMCID: PMC7466867          DOI: 10.1016/j.molmed.2018.05.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  113 in total

1.  Palmitoylation is required for efficient Fas cell death signaling.

Authors:  Krittalak Chakrabandhu; Zoltán Hérincs; Sébastien Huault; Britta Dost; Ling Peng; Fabien Conchonaud; Didier Marguet; Hai-Tao He; Anne-Odile Hueber
Journal:  EMBO J       Date:  2006-12-07       Impact factor: 11.598

2.  Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.

Authors:  Sanja Stevanović; Anna Pasetto; Sarah R Helman; Jared J Gartner; Todd D Prickett; Bryan Howie; Harlan S Robins; Paul F Robbins; Christopher A Klebanoff; Steven A Rosenberg; Christian S Hinrichs
Journal:  Science       Date:  2017-04-14       Impact factor: 47.728

3.  Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15.

Authors:  Yang Xu; Ming Zhang; Carlos A Ramos; April Durett; Enli Liu; Olga Dakhova; Hao Liu; Chad J Creighton; Adrian P Gee; Helen E Heslop; Cliona M Rooney; Barbara Savoldo; Gianpietro Dotti
Journal:  Blood       Date:  2014-04-29       Impact factor: 22.113

4.  Specific elimination of effector memory CD4+ T cells due to enhanced Fas signaling complex formation and association with lipid raft microdomains.

Authors:  M Ramaswamy; A C Cruz; S Y Cleland; M Deng; S Price; V K Rao; R M Siegel
Journal:  Cell Death Differ       Date:  2010-12-17       Impact factor: 15.828

5.  Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.

Authors:  Christopher A Klebanoff; Luca Gattinoni; Parizad Torabi-Parizi; Keith Kerstann; Adela R Cardones; Steven E Finkelstein; Douglas C Palmer; Paul A Antony; Sam T Hwang; Steven A Rosenberg; Thomas A Waldmann; Nicholas P Restifo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-24       Impact factor: 11.205

6.  Requirement for caspase-8 in NF-kappaB activation by antigen receptor.

Authors:  Helen Su; Nicolas Bidère; Lixin Zheng; Alan Cubre; Keiko Sakai; Janet Dale; Leonardo Salmena; Razqallah Hakem; Stephen Straus; Michael Lenardo
Journal:  Science       Date:  2005-03-04       Impact factor: 47.728

7.  Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.

Authors:  Hyung J Chun; Lixin Zheng; Manzoor Ahmad; Jin Wang; Christina K Speirs; Richard M Siegel; Janet K Dale; Jennifer Puck; Joie Davis; Craig G Hall; Suzanne Skoda-Smith; T Prescott Atkinson; Stephen E Straus; Michael J Lenardo
Journal:  Nature       Date:  2002-09-26       Impact factor: 49.962

8.  Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Authors:  Shannon L Maude; Theodore W Laetsch; Jochen Buechner; Susana Rives; Michael Boyer; Henrique Bittencourt; Peter Bader; Michael R Verneris; Heather E Stefanski; Gary D Myers; Muna Qayed; Barbara De Moerloose; Hidefumi Hiramatsu; Krysta Schlis; Kara L Davis; Paul L Martin; Eneida R Nemecek; Gregory A Yanik; Christina Peters; Andre Baruchel; Nicolas Boissel; Francoise Mechinaud; Adriana Balduzzi; Joerg Krueger; Carl H June; Bruce L Levine; Patricia Wood; Tetiana Taran; Mimi Leung; Karen T Mueller; Yiyun Zhang; Kapildeb Sen; David Lebwohl; Michael A Pulsipher; Stephan A Grupp
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

9.  A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication.

Authors:  Jing Zhou; Michael T Bethune; Natalia Malkova; Alexander M Sutherland; Begonya Comin-Anduix; Yapeng Su; David Baltimore; Antoni Ribas; James R Heath
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

10.  Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy.

Authors:  Madhusudhanan Sukumar; Jie Liu; Gautam U Mehta; Shashank J Patel; Rahul Roychoudhuri; Joseph G Crompton; Christopher A Klebanoff; Yun Ji; Peng Li; Zhiya Yu; Greg D Whitehill; David Clever; Robert L Eil; Douglas C Palmer; Suman Mitra; Mahadev Rao; Keyvan Keyvanfar; David S Schrump; Ena Wang; Francesco M Marincola; Luca Gattinoni; Warren J Leonard; Pawel Muranski; Toren Finkel; Nicholas P Restifo
Journal:  Cell Metab       Date:  2015-12-08       Impact factor: 27.287

View more
  26 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

2.  Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expression.

Authors:  Ming-Jenn Chen; Po-Ming Chen; Lee Wang; Ching-Ju Shen; Chi-Yi Chen; Huei Lee
Journal:  Am J Cancer Res       Date:  2020-04-01       Impact factor: 6.166

3.  Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity.

Authors:  Catriona A Wagner; Pamela J Roqué; Trevor R Mileur; Denny Liggitt; Joan M Goverman
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

4.  Costimulation Blockade Disrupts CD4+ T Cell Memory Pathways and Uncouples Their Link to Decline in β-Cell Function in Type 1 Diabetes.

Authors:  Martin Eichmann; Roman Baptista; Richard J Ellis; Susanne Heck; Mark Peakman; Craig A Beam
Journal:  J Immunol       Date:  2020-05-13       Impact factor: 5.422

5.  T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.

Authors:  Tori N Yamamoto; Ping-Hsien Lee; Suman K Vodnala; Devikala Gurusamy; Rigel J Kishton; Zhiya Yu; Arash Eidizadeh; Robert Eil; Jessica Fioravanti; Luca Gattinoni; James N Kochenderfer; Terry J Fry; Bulent Arman Aksoy; Jeffrey E Hammerbacher; Anthony C Cruz; Richard M Siegel; Nicholas P Restifo; Christopher A Klebanoff
Journal:  J Clin Invest       Date:  2019-02-25       Impact factor: 14.808

Review 6.  All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity.

Authors:  Ariel Ramírez-Labrada; Cecilia Pesini; Llipsy Santiago; Sandra Hidalgo; Adanays Calvo-Pérez; Carmen Oñate; Alejandro Andrés-Tovar; Marcela Garzón-Tituaña; Iratxe Uranga-Murillo; Maykel A Arias; Eva M Galvez; Julián Pardo
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

Review 7.  Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword.

Authors:  Anthony M Battram; Mireia Bachiller; Beatriz Martín-Antonio
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

8.  TRAIL inhibits platelet-induced colorectal cancer cell invasion.

Authors:  Li-Sha Wu; Xiao-Wei Wang; Wen He; Xiao-Ting Ma; Hai-Yue Wang; Mei Han; Bing-Hui Li
Journal:  J Int Med Res       Date:  2019-01-09       Impact factor: 1.671

Review 9.  Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy.

Authors:  Olivia A Diaz Arguello; Hidde J Haisma
Journal:  Cancers (Basel)       Date:  2021-03-27       Impact factor: 6.639

10.  Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment.

Authors:  Lin Cao; Weisha Li; Xingjiu Yang; Wenlong Zhang; Mengyuan Li; Haizeng Zhang; Chuan Qin; Xiaohong Chen; Ran Gao
Journal:  Cancer Gene Ther       Date:  2021-06-22       Impact factor: 5.854

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.